近十年完整腹主动脉瘤腔内修复术30天死亡率和并发症的趋势
该研究基于美国国家外科质量改进计划数据库,纳入2006至2015年接受完整腹主动脉瘤腔内修复术(EVAR)的30076例患者,比较早期(2006-2010年)与晚期(2011-2015年)的围手术期结局。结果显示30天死亡率保持低位(1.2% vs 1.2%,P=0.98),但晚期手术时间、住院时间和30天主要并发症均显著降低。
要点
- 晚期EVAR的30天主要并发症率较早期降低19.6%(5.1% vs 4.1%,P<0.0001)。
- 晚期手术时间(141.9±73.7分钟 vs 155.5±72.6分钟)和住院时间(2.81±4.30天 vs 3.24±5.32天)均显著缩短。
- 晚期治疗与30天主要并发症降低独立相关(OR 0.75,95%CI 0.65-0.87,P<0.001)。
核心结论
- 尽管30天死亡率保持相似,但近十年EVAR术后并发症显著下降,移植物技术及手术技巧的持续改进带来了手术时间缩短、手术并发症显著减少和住院时间缩短。
研究设计与样本
- 基于美国国家外科质量改进计划数据库的回顾性研究,纳入2006至2015年接受完整腹主动脉瘤EVAR的患者30076例,分为早期(2006-2010年,n=11539)和晚期(2011-2015年,n=18537)两组。
主要发现
- 30天死亡率在早期组为1.2%,晚期组为1.2%(P=0.98)。
- 平均手术时间早期组为155.5±72.6分钟,晚期组为141.9±73.7分钟(P<0.001)。
- 平均住院时间早期组为3.24±5.32天,晚期组为2.81±4.30天(P<0.001)。
- 30天主要并发症率早期组为5.1%,晚期组为4.1%,降低19.6%(P<0.0001)。
- 晚期组肾功能衰竭(1.4% vs 1.0%,P=0.003)、心肺并发症(2.2% vs 1.7%,P=0.006)和伤口并发症(2.5% vs 1.8%,P<0.001)均较早期组降低。
关键数值与推荐
- 晚期治疗与30天主要并发症降低独立相关(OR 0.75,95%CI 0.65-0.87,P<0.001),倾向性评分匹配队列中亦得到证实(OR 0.76,95%CI 0.66-0.90,P<0.001)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Significant research efforts have been made to improve the safety and efficacy of endovascular aneurysm repair (EVAR) in treating abdominal aortic aneurysm. This study aimed to examine the trends of perioperative outcomes of EVAR in the recent decade using a national validated database. METHODS: Patients who underwent EVAR for intact abdominal aortic aneurysm between 2006 and 2015 were identified from the National Surgical Quality Improvement Program and divided into early (2006-2010) and late (2011-2015) periods. The primary outcome of the study was 30-day mortality. Secondary outcomes included operative time, length of hospital stay, and 30-day major complications (renal, cardiopulmonary, and wound infection). RESULTS: A total of 30,076 patients were identified, with 11,539 in the early period and 18,537 in the late period. The 30-day mortality was kept at a low level in both periods (1.2% vs 1.2%; P = .98), whereas both the mean operation time (155.5 ± 72.6 minutes vs 141.9 ± 73.7 minutes; P < .001) and length of hospital stay (3.24 ± 5.32 days vs 2.81 ± 4.30 days; P < .001) were decreased in the late period. The 30-day major complication rate was reduced by 19.6% (5.1% vs 4.1%; P < .0001), with decreased renal failure (1.4% vs 1.0%; P = .003), cardiopulmonary complications (2.2% vs 1.7%; P = .006), and wound complications (2.5% vs 1.8%; P < .001). All the decreasing trends of mortality, any 30-day complication, and each type of major complication were statistically significant. Being treated in the late period was independently associated with decreased 30-day major complications (odds ratio, 0.75; 95% confidence interval, 0.65-0.87; P < .001), and this effect was confirmed in the propensity score-matched cohort (odds ratio, 0.76; 95% confidence interval, 0.66-0.90; P < .001). CONCLUSIONS: Although the 30-day mortality remains similar, postoperative complications in EVAR have decreased significantly during the recent decade. The continuous improvement in endograft technology and surgical skills has resulted in decreased operative time, marked reduction in surgical complications, and shorter hospital length of stay after endovascular repair.
引用
- Yin K, Locham SS, Schermerhorn ML, et al. Trends of 30-day mortality and morbidities in endovascular repair of intact abdominal aortic aneurysm during the last decade. J Vasc Surg. 2018. PMID: 29914839. doi:10.1016/j.jvs.2018.04.032
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。